Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 27 Sep 21 EFFECT Notice of effectiveness
- 24 Sep 21 424B3 Prospectus supplement
- 22 Sep 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
8 Sep 21 S-4 Registration of securities issued in business combination transactions
BVS similar filings
Filing view
External links
Exhibit 99.3
Consent to Reference in Joint Proxy Statement/Prospectus
Bioventus Inc. (the “Company”) is filing a Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the joint proxy statement/prospectus included in such Registration Statement as a future member of the board of directors of the Company, such appointment to commence upon the closing of the transactions described in the joint proxy statement/prospectus.
Sincerely,
/s/ Stavros G. Vizirgianakis